We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$412M
AUM Growth
-$28.5M
Cap. Flow
+$526K
Cap. Flow %
0.13%
Top 10 Hldgs %
53.73%
Holding
356
New
17
Increased
33
Reduced
56
Closed
13

Sector Composition

Rank Sector Weight
1 Real Estate 2.97%
2 Consumer Discretionary 1.95%
3 Technology 1.17%
4 Healthcare 0.54%
5 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBDN
76
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$290K 0.07%
11,595
-281
-2% -$7.03K
CVS icon
77
CVS Health
CVS
$122B
$286K 0.07%
3,000
VSS icon
78
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$256K 0.06%
2,755
SCHH icon
79
Schwab US REIT ETF
SCHH
$11.4B
$253K 0.06%
13,538
-35
-0.3% -$757
ACN icon
80
Accenture
ACN
$108B
$241K 0.06%
937
-78
-8% -$22.5K
IBDR icon
81
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.4B
$233K 0.06%
10,105
AJG icon
82
Arthur J. Gallagher & Co
AJG
$63.6B
$226K 0.05%
1,322
-103
-7% -$18.3K
ORCL icon
83
Oracle
ORCL
$423B
$226K 0.05%
3,700
IBDS icon
84
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.85B
$225K 0.05%
9,779
ENB icon
85
Enbridge
ENB
$112B
$219K 0.05%
5,890
SKT icon
86
Tanger
SKT
$4.52B
$219K 0.05%
16,000
JNJ icon
87
Johnson & Johnson
JNJ
$625B
$217K 0.05%
1,330
IBDT icon
88
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
$216K 0.05%
9,096
IBM icon
89
IBM
IBM
$224B
$210K 0.05%
1,767
-157
-8% -$20.6K
QCOM icon
90
Qualcomm
QCOM
$176B
$209K 0.05%
1,847
+5
+0.3% +$687
PG icon
91
Procter & Gamble
PG
$339B
$207K 0.05%
1,643
ADP icon
92
Automatic Data Processing
ADP
$108B
$205K 0.05%
906
USRT icon
93
iShares Core US REIT ETF
USRT
$4.63B
$203K 0.05%
4,275
-16,361
-79% -$901K
VOT icon
94
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$203K 0.05%
1,193
PNC icon
95
PNC Financial Services
PNC
$101B
$179K 0.04%
1,200
CTVA icon
96
Corteva
CTVA
$51.3B
$171K 0.04%
3,000
C icon
97
Citigroup
C
$226B
$167K 0.04%
4,000
CSCO icon
98
Cisco
CSCO
$479B
$165K 0.04%
4,134
-488
-11% -$21.7K
SPDW icon
99
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.6B
$165K 0.04%
6,392
IVOO icon
100
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.83B
$163K 0.04%
2,192
-560
-20% -$45.8K

Similar funds

Roble Belko & Company's Q3 2022 Portfolio in Review

As of Q3 2022, Roble Belko & Company held 356 positions worth $412M, down 6.5% from $440M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Roble Belko & Company's Q3 2022 filing shows 17 new, 33 increased, 56 reduced and 13 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 173,837 shares worth $10.1M. The largest sale was Vanguard Ultra-Short Bond ETF, an estimated $6.03M.

By sector, the portfolio is most concentrated in Real Estate at 3% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Roble Belko & Company's largest Q3 2022 buy was Vanguard Intermediate-Term Treasury ETF: 173,837 shares worth $10.1M.
  • Roble Belko & Company added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $6.63M increase.
  • Roble Belko & Company's biggest Q3 2022 reduction was Vanguard Ultra-Short Bond ETF, cutting an estimated $6.03M.
  • Roble Belko & Company fully exited Vanguard S&P Small-Cap 600 ETF in Q3 2022, selling an estimated $43K.
  • Roble Belko & Company's ten largest holdings make up 54% of its $412M portfolio in Q3 2022.
  • Roble Belko & Company opened 17 new positions and closed 13 in Q3 2022.
  • Roble Belko & Company's portfolio value fell 6.5% quarter-over-quarter to $412M.

Based on Roble Belko & Company's 13F filing for Q3 2022, filed 14 Nov 2022.